Tirzepatide Dosing: Your Complete Week-by-Week Guide

Tirzepatide follows a structured dose escalation that has been carefully designed based on clinical trial protocols. The schedule ensures your body adjusts gradually, minimizing side effects while building toward an effective therapeutic dose. Weeks 1-4: 2.5mg weekly — This is your starting dose. The primary goal is tolerance-building rather than maximum weight loss. You may notice mild appetite reduction and some early side effects as your body adjusts. Weeks 5-8: 5mg weekly — The first dose increase. Many patients begin to notice more significant appetite suppression at this level. Some early weight loss becomes apparent. Weeks 9-12: 7.5mg weekly — Appetite suppression strengthens further. Weight loss typically accelerates during this phase. Most patients are losing 1-2 pounds per week consistently. Weeks 13-16: 10mg weekly — A significant therapeutic dose. Many patients achieve excellent results at this level and may not need further escalation. Weeks 17-20: 12.5mg weekly — For patients who need additional effect beyond 10mg. Weeks 21+: 15mg weekly — The maximum approved dose. Reserved for patients who tolerate lower doses well but need the maximum effect for their weight loss goals. At A Touch Above MedSpa, this schedule is a guideline, not a rigid protocol. Dr. Singh adjusts timing based on your individual response.

The standard escalation schedule works well for many patients, but medical weight loss is not one-size-fits-all. Dr. Shailender Singh at A Touch Above MedSpa personalizes the dosing approach based on several factors. Tolerance assessment: If you experience significant nausea or GI discomfort at a particular dose, Dr. Singh may extend the time at that level — spending 6-8 weeks instead of 4 — before escalating. This slower approach reduces side effects without sacrificing long-term results. Weight loss response: Some patients achieve their target rate of weight loss (approximately 2 pounds per week) at lower doses. If you are losing weight effectively at 10mg, there may be no need to escalate to 12.5mg or 15mg. The goal is the lowest effective dose, not the maximum dose. Health markers: Blood sugar, blood pressure, and other metabolic markers are monitored throughout treatment. Improvements in these markers help guide dosing decisions beyond weight loss alone. Prior GLP-1 experience: Patients transitioning from semaglutide to tirzepatide may tolerate dose escalation differently than GLP-1-naive patients. Dr. Singh accounts for this in the dosing plan. Our injections are mixed with B12 at every dose level, providing consistent energy support throughout your treatment.

Once you reach your therapeutic dose and are losing weight at a healthy, sustainable rate, the focus shifts to maintenance. This is the dose at which you continue treatment for the duration of your weight loss program — typically 6-12 months or longer depending on your goals. Maintenance dosing is not static. As you lose weight, your metabolic needs change. Dr. Singh may adjust your dose if weight loss plateaus, side effects change, or your health markers suggest a different dose would be more appropriate. When you approach your goal weight, a long-term strategy is developed. Options include continuing at a lower maintenance dose to prevent weight regain, gradual tapering over several months while monitoring for weight regain, and transitioning to lifestyle-only maintenance with periodic check-ins. The tapering approach is particularly important with tirzepatide. Abruptly stopping the medication can lead to rapid weight regain as appetite returns to pre-treatment levels. A gradual step-down allows your body and eating habits to adjust. Dr. Singh at A Touch Above MedSpa creates a detailed tapering plan individualized to each patient.